Medicare Benefits Schedule - Item 73339

Search Results for Item 73339

View Associated Notes

Category 6 - PATHOLOGY SERVICES

73339

73339 - Additional Information

Item Start Date:
01-Nov-2014
Description Updated:
01-Nov-2014
Schedule Fee Updated:
01-Nov-2014

Group
P7 - Genetics

Detection of germline mutations in the RET gene in patients with a suspected clinical diagnosis of multiple endocrine neoplasia type 2 (MEN2) requested by a specialist or consultant physician who manages the treatment of the patient.


One test.  (Item is  subject to rule 25)

Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

(See para PN.0.23 of explanatory notes to this Category)


Associated Notes

Category 6 - PATHOLOGY SERVICES

PN.0.23

Detection of mutation tests (Items 73297, 73300, 73305, 73334, 73339 and 73340)

Prior to ordering these tests (73297, 73300, 73305, 73334, 73339 and 73340) the ordering practitioner should ensure the patient (or approximate proxy) has given informed consent. Testing should only be performed after genetic counselling. Appropriate genetic counselling should be provided to the patient either by the specialist treating practitioner, a genetic counselling service or a clinical geneticist on referral. Further counselling may be necessary upon receipt of the test results.

Related Items: 73297 73300 73305 73334 73339 73340


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change